On Jun 6, 2014, Digital Ally, Inc. (NASDAQ: DGLY) the industry leader in law enforcement video technology, announced that it has filed an Unfair Competition lawsuit against Utility Associates, Inc. (“Utility”) in the United States District Court for the District of Kansas. Digital Ally, Inc. (NASDAQ:DGLY) net profit margin is -14.00% and weekly performance is -27.66%. On last trading day company shares ended up $3.61. Analysts mean target price for the company is $4.00. Digital Ally, Inc. (NASDAQ:DGLY) distance from 50-day simple moving average (SMA50) is -26.87%.
Skyline Corporation (NYSEMKT:SKY) shares fell -5.39% in last trading session and ended the day on $4.21 . Gross Margin is 6.90 % and its return on assets is -14.10%. Skyline Corporation (NYSEMKT:SKY) quarterly performance is -23.45%.
On June 4, Così Inc. (NASDAQ:COSI) said this week that Stephen Edwards is stepping down as executive chairman and won’t stand for re-election to the board when his term expires this year. Cosi Inc (NASDAQ:COSI) shares moved down -8.00 % in last trading session and was closed at $1.15, while trading in range of $1.15 – $1.28. Cosi Inc (NASDAQ:COSI) year to date (YTD) performance is -31.55%.
On June 2, 2014 BOS Better OnLine Sol (USA) (NASDAQ:BOSC) a leading Israeli provider of RFID and supply chain solutions to global enterprises, announced that it has entered into an exclusive distribution agreement with Sigur Capital Ltd., for the provision of BOS products and solutions to the African market. Sigur Capital and its affiliate Sigur Tech shall also provide implementation and services to the BOS products and solutions in Africa. BOS Better OnLine Sol (USA) (NASDAQ:BOSC) ended the last trading day at $3.95. Company weekly volatility is calculated as 4.12% and price to cash ratio as 10.27. BOS Better OnLine Sol (USA) (NASDAQ:BOSC) showed a negative weekly performance of -6.40%.
On May 21, 2014, DS Healthcare Group, Inc. (NASDAQ:DSKX) a leading developer of personal care products and specialty pharmaceuticals, announced it has appointed Dr. Brijeshkumar Patel, PhD to the newly created position of Director of Research and Development. In this role Dr. Patel will focus on the development of transdermal drug delivery systems for the Company’s hair-care products, as well as restructuring existing and new molecules for increased absorption and effectiveness. DS Healthcare Group Inc (NASDAQ:DSKX) net profit margin is -27.00% and weekly performance is 3.85%. On last trading day company shares ended up $1.89. Analysts mean target price for the company is $5.50. DS Healthcare Group Inc (NASDAQ:DSKX) distance from 50-day simple moving average (SMA50) is -1.38%.